Title : Durable Response of Spinal Chordoma to Combined Inhibition of IGF-1R and EGFR.

Pub. Date : 2016

PMID : 27200287






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In June 2009, she was recruited onto the Phase I OSI-906-103 trial of EGFR inhibitor erlotinib with linsitinib, a novel inhibitor of IGF-1R/insulin receptor (INSR). 3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol insulin receptor Homo sapiens